Benjamin Schneider is a PhD-trained quantitative pharmacologist and founder with 11 years of experience translating complex biological problems into predictive models and practical programs. He has led DMPK and PK/PD efforts across preclinical to phase III clinical development at Agios and Metrum Research Group while also consulting in pharmacometrics and collaborating with industry partners like Eli Lilly and Ceva. Based in Cincinnati, he combines rigorous modeling and simulation expertise with hands-on leadership—mentoring junior scientists, coordinating CROs, and representing programs in clinical working groups. Outside pharma he co-founded a vegan food supplier and launched a local nonprofit, signaling a maker-entrepreneurial streak and commitment to community impact. His background in physics and mathematics underpins a data-first approach to drug development and an interest in emergent intelligence that bridges science and engineering. Colleagues would describe him as a pragmatic modeler who turns complex theory into useful, mission-driven solutions.
11 years of coding experience
9 years of employment as a software developer
Doctor of Philosophy - PhD, Modeling and Simulation in Pharmacology, Doctor of Philosophy - PhD, Modeling and Simulation in Pharmacology at Iowa State University
Bachelor of Science (B.S.), Physics, Bachelor of Science (B.S.), Physics at Indiana University Bloomington
Contributions:35 commits, 29 pushes, 1 branch in 1 year 6 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Benjamin Schneider - Founder And Director at BE Good Foods LLC